BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1631 related articles for article (PubMed ID: 30480801)

  • 21. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway.
    Zhang F; Liu J; Xie BB
    J Cell Physiol; 2019 Aug; 234(10):18626-18638. PubMed ID: 31049956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
    Wang F; Tan WH; Liu W; Jin YX; Dong DD; Zhao XJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1891-1898. PubMed ID: 29687840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing.
    Jin Y; Tymen SD; Chen D; Fang ZJ; Zhao Y; Dragas D; Dai Y; Marucha PT; Zhou X
    PLoS One; 2013; 8(5):e64434. PubMed ID: 23724047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway.
    Han S; Chen Y; Gao Y; Sun B; Kong Y
    Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2.
    Liao D; Liu X; Yuan X; Feng P; Ouyang Z; Liu Y; Li C
    Cell Cycle; 2022; 21(6):572-584. PubMed ID: 35090377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines.
    Chen T; Shao S; Li W; Liu Y; Cao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3638-3648. PubMed ID: 31456425
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S; Zhang Y; Huang C; Lin S
    J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K/AKT/mTOR pathway.
    Wang W; Zhang J; Fan Y; Zhang L
    Cell Cycle; 2022 Jul; 21(14):1491-1501. PubMed ID: 35416128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of lncRNA ANRIL aggravated hydrogen peroxide-disposed injury in PC-12 cells via inhibiting miR-499a/PDCD4 axis-mediated PI3K/Akt/mTOR/p70S6K pathway.
    Guo Z; Li L; Gao Y; Zhang X; Cheng M
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2624-2633. PubMed ID: 31220946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
    Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
    Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.